000119
10.3205/000119
urn:nbn:de:0183-0001195
Research Article
Does hypernatremia impact mortality in Toxic Epidermal Necrolysis?
Wird die Mortalität bei Toxisch Epidermaler Nekrolyse durch eine Hypernatriämie beeinflusst?
Namdar
Namdar
Thomas
T
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, GermanyDepartment of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
thomas.namdar@uk-sh.de
author
von Wild
von Wild
Tobias
T
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
Siemers
Siemers
Frank
F
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
Stollwerck
Stollwerck
Peter L.
PL
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
Stang
Stang
Felix H.
FH
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
Mailänder
Mailänder
Peter
P
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
Lange
Lange
Thomas
T
Department of Plastic and Hand Surgery, Burn Unit, University Hospital Schleswig-Holstein Campus Lübeck, Germany
author
German Medical Science GMS Publishing House
Düsseldorf
610
Toxic Epidermal Necrolysis
hypernatremia
intensive care
Toxisch Epidermale Nekrolyse
Hypernatriämie
Intensivmedizin
20100802
20101020
20101102
engl
1612-3174
8
GMS German Medical Science
GMS Ger Med Sci
30
Einleitung: Hypernatriämien gehen bei schwerstkranken Patienten mit einer erhöhten Mortalität einher. Die kausalen Zusammenhänge sind noch weitgehend unklar. Ziel dieser Studie war es festzustellen, ob hypernatriäme Patienten mit einer Toxisch Epidermalen Nekrolyse (TEN) eine erhöhte Mortalität aufweisen. Material und Methoden: Retrospektive Studie an 25 TEN-Patienten. Es erfolgte die Differenzierung in normonatriäm (Gruppe A) und hypernatriäm (Gruppe B). Neben dem Serum-Natrium-Verlauf wurden die tägliche Diuresemenge und die Mortalitätsrate analysiert. Ergebnisse: In Gruppe A konnten 10 Patienten mit einer Epidermolyse von 74±25% der Köperoberfläche (KOF) und einem SCORTEN von 2,7±0,9 eingeschlossen werden. Die Diurese innerhalb der ersten 10 Tage betrug 1±0,3 ml/kg/Stunde. In Gruppe B wurden 15 Patienten mit einer Epidermolyse von 76±19% der KOF und einem SCORTEN von 3,5±1 eingeschlossen. Die durchschnittliche Diurese innerhalb der ersten 10 Tage betrug 1,4±0,4 ml/kg/Stunde. Eine Hypernatriämie wurde am 3. ±2 Tage nach der stationären Einweisung manifest und persistierte für 5±3 Tage. Die statistische Analyse ergab eine signifikant höhere Diurese (p=0,007) und SCORTEN (p=0,04) in Gruppe B. Ein normonatriämer and 8 hypernatriäme Patienten verstarben auf der Intensivstation. In Gruppe B wurde eine signifikant höhere Mortalität berechnet (Odds Ratio: 13,5; 95% Konfidenz-Intervall: 1,34–135,98; p 0,01).Schlussfolgerung: Hypernatriäme Patienten, welche an einer TEN erkrankt sind, haben ein erhöhtes Mortalitätsrisiko. Eine engmaschige Kontrolle der Elektrolyte erscheint daher empfehlenswert.
Introduction: In-hospital hypernatremia is associated with increased mortality rates. We want to elucidate the impact of in-hospital acquired hypernatremia in mortality of Toxic Epidermal Necrolysis (TEN).Purpose: Is there an association between hypernatremia and mortality in patients with TEN?Method: Retrospective study of 25 patients with TEN. Laboratory electrolyte results, diuresis and survival were analyzed. Patients were separated in two groups without (Group A) or with (Group B) hypernatremia.Results: In Group A 10 patients with a TBSA of 74±25% (mean ± standard deviation), and a SCORTEN-Score of 2.7±0.9 were summarized. Diuresis within the first 10 days after admission was 1±0.3 ml/kg/hour. In Group B 15 patients with a TBSA of 76±19%, and a SCORTEN-Score of 3.5±1 were included. Diuresis within the first 10 days after admission was 1.4±0.4 ml/kg/hour. Hypernatremia occurred on day 3.3±2.4 after admission and persisted for 5.3±2.9 days. Statistical analysis showed a significantly higher diuresis (p=0.007) and SCORTEN-Score (p=0.04) in the hypernatremic patients. One normonatremic and 8 hypernatremic patients died during ICU-stay (overall mortality rate 36%). A significantly higher mortality rate was found in Group B (odds ratio: 13,5; 95% confidence interval: 1.34–135.98; p=0.01) during ICU-stay.Conclusion: TEN patients with an in-hospital acquired hypernatremia have an increased mortality risk. Close electrolyte monitoring is advisable in these patients.
IntroductionToxic Epidermal Necrolysis (TEN) is a rare disease with an incidence of approximately 1–2 per million/year , . Prodromi are unspecific symptoms like fever and malaise. TEN is clinically diagnosed by cutaneous eryt<![CDATA[hem</PlainText></TextGroup>a, progressive blistering, epidermolysis (>30% Total Body Surface Area (TBSA)), mucosal erosions, and/or ophthalmic affection. The cutaneous eruption is characterized by the Nikolsky sign, which is defined as epidermolysis with mobility of the affected epidermis upon healthy skin and epidermal detachment on the slightest friction <TextLink reference="3"></TextLink>. Skin biopsy is the only reliable method to confirm the diagnosis of TEN (separation of the epidermo-dermal junction) in correlation with the macroscopic clinical presentation of the skin <TextLink reference="4"></TextLink>. Burn center treatment is recommended in TEN-patients, because of the extensive cutaneous defects <TextLink reference="5"></TextLink>.</Pgraph><Pgraph>High mortality rates of TEN have been reported (14 to 70%) <TextLink reference="6"></TextLink>, <TextLink reference="7"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink>. The independent predictors of mortality in TEN are Age (>40 years), heart rate (>120/min), presence of malignant tumors, initial epidermolysis (>10% affected surface area), serum urea (>10 mmol/l), serum bicarbonate (<20 mmol/l), and serum glucose (>14 mmol/l). These variables are described by Bastuji-Garin et al. after evaluating epidemio<TextGroup><PlainText>logi</PlainText></TextGroup>c and diagnostic parameters <TextLink reference="10"></TextLink>.</Pgraph><Pgraph>Hypernatremia (>145 mmol/) is a common electrolyte disorder characterized by a deficit of total-body water r<TextGroup><PlainText>el</PlainText></TextGroup>ative to total-body sodium <TextLink reference="11"></TextLink>. Hypernatremia can result from water loss, or hypertonic sodium gain. It is almost never found in an alert patient with a normal thirst mechanism and access to water. The two main defense mechanisms against hypernatremia are thirst and stimulation of vasopressin release <TextLink reference="12"></TextLink>. Hypernatremia can be classified according to the patient's volume status (hypovolemia, euvolemia, hypervolemia). In hypovolemic hypernatremia free water loss exceeds sodium loss, whereas patients with an euvolemic hypernatremic state have pure water loss without signs of hypovolemia. Hypervolemic hypernatremia, caused by a pure sodium overload is rare and frequently caused iatrogenically, by excessive sodium administration, overcorrection of hyponatremia, hypertonic dialysate, and hypertonic enteral or parenteral hyperalimentation. Noniatrogenic etiologies include various mineralocorticoid deficiencies, salt water neardrownings, ingestion of improperly prepared infant formula, and ingestion of salt tablets. Free water loss can result from extrarenal (i.e. sweating, burns, diarrhea, skin diseases) or renal (diuretics, severe osmotic diure<TextGroup><PlainText>si</PlainText></TextGroup>s, severe glucosuria in diabetics, or elevated urea in postobstructive diuresis) causes <TextLink reference="12"></TextLink>. It is difficult to distinguish whether these high mortality rates are caused by the hypernatremia itself, the underlying disease process, or the sequelae of hypernatremia treatment <TextLink reference="13"></TextLink>.</Pgraph><Pgraph>In non-TEN critically ill patients an acquired hypernatremic state appears to be associated with increased mortality rates (range from 31% to 66%) <TextLink reference="13"></TextLink>, <TextLink reference="14"></TextLink>, <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>, <TextLink reference="17"></TextLink>, <TextLink reference="18"></TextLink>, <TextLink reference="19"></TextLink>. We present a retrospective study to elucidate the impact of in-hospital acquired hypernatremia on mortality.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Materials and methods">
<MainHeadline>Materials and methods</MainHeadline><Pgraph>Fifty-two patients with a severe cutaneous drug reaction were treated during the past 10 years. Twenty-five patients with TEN (epidermolysis >30% TBSA) were identified retrospectively. Patients with an epidermolysis <30% TBSA were excluded from this study, because of the lower severity of illness and to provide a better comparability in with previous studies in the TEN group. Hemodynamic monitoring was realized by continuous invasive blood pressure measurement. To achieve a balanced fluid regimen, urinary output, mean arterial blood pressure, and blood gas analysis were performed every 1–3 hours. Transdermal water loss (epidermolytic skin) was calculated with 40 ml/%-TBSA/day. Amount and type of infusate (Ringer's solution, glucose 5%) and/or diuretics (e.g. Furosemid) were adjusted to individual requirements. Hypernatremia was defined at serum sodium levels ≥146 mmol/l. Hypernatremia was treated immediately with an increased infusion rate of electrolyte free water (glucose 5%).</Pgraph><Pgraph>Statistics were performed with SPSS<Superscript>®</Superscript> 15.0 (SPSS Inc., Chicago, USA). To estimate significance Mann-Whitney-U- or CHI-square-test were performed. Results are written in mean value ± standard deviation. Survival was calculated using Kaplan-Meier method; logrank (Mantel-Cox) analysis was used to calculate statistical significance.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Results">
<MainHeadline>Results</MainHeadline><Pgraph>25 (17 female; 8 male) patients with a mean age of 59±18 years, a mean epidermolysis surface of 76.4±19%, and a mean SCORTEN-Score of 3.2±1 were included. Mean urinary output was 1.2±0.4 ml/hour within the first 10 days after admission. Patients were separated into two groups: Group A (without) and Group B (with) in-hospital acquired hypernatremia.</Pgraph><Pgraph>In Group A, 10 patients (5 female; 5 male) were summarized. Mean age, affected TBSA, SCORTEN, diuresis, serum sodium level (on admission), amount of furorese and daily infusion-diuresis-ratio (IDR) (for day 1 to 4 and day 1 to 10) are given in Table 1 <ImgLink imgNo="1" imgType="table"/>. Four patients showed a mucosal involvement. Mean creatinine (10 days after admission) was 65±27 µmol/l. Six patients (60%) did not receive any diuretic medication. There was no elevated serum sodium level in Group A within the first 10 days after admission.</Pgraph><Pgraph>In Group B 15 patients (12 female; 3 male) were included. Mean age, affected TBSA, SCORTEN, diuresis, serum sodium level (on admission), amount of furorese and daily IDR (for day 1 to 4 and day 1 to 10) are given in Table 1 <ImgLink imgNo="1" imgType="table"/>. Five patients showed a mucosal involvement. Mean creatinine (10 days after admission) was 93±49 µmol/l. Four patients (27%) did not receive any diuretic medication. Hypernatremia occurred on day 3.3±2.4 after admission and persisted for 5.3±2.9 days. </Pgraph><Pgraph>No significant differences in age, sex, affected TBSA, mucosal involvement and daily amount of furorese applied (over a 10-days-period) and daily IDR were found between Group A and Group B. Statistical analysis showed a significantly higher mean creatinine within 10 days after admission (p=0.025), higher diuresis (p=0.007), higher mean serum sodium levels on admission (p=0.004), and a higher SCORTEN-Score (p=0.04) in Group B (Table 1 <ImgLink imgNo="1" imgType="table"/>). </Pgraph><Pgraph>One normonatremic and 8 hypernatremic patients died during ICU-stay (overall mortality 36%). A significantly higher mortality rate was found in Group B (odds ratio: 13,5; 95% confidence interval: 1.34–135.98; p=0.01) during ICU-stay (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). 4 patients died in a septic state due to pneumonia, 2 patients died after myocardial infarction, and 1 patient died due to a pulmonary embolism. The remaining 2 patients died of multi-organ failure for which no pathologic mechanism could be identified.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Discussion">
<MainHeadline>Discussion</MainHeadline><Pgraph>TEN is a rare, but life-threatening, exfoliative dermatitis, affecting the skin and mucous membranes. The large open surface caused by epidermolysis, leads to an enormous transdermal fluid loss of up to 4 liters per day <TextLink reference="8"></TextLink>. In TEN, fluid regimen cannot be performed in a standardized way. The type and the amount of infusate need to be adjusted to individual parameters such as the extent of epidermolysis, body weight, and co-morbidities such as renal insufficiency, chronic or acute pulmonary disease and cardiac dysfunction. A well balanced infusion-diuresis-ratio has to be achieved and monitored vigilantly. Bastuji-Garin et al. described a scoring system (SCORTEN) that enables the physician to determine the severity of the illness and risk of death on admission of TEN patients <TextLink reference="10"></TextLink>. Age, tachycardia, presence of malignancy, initial epidermolysis, serum urea, serum bicarbonate, and serum glucose have been shown to predict mortality in TEN <TextLink reference="10"></TextLink>.</Pgraph><Pgraph>In-hospital acquired hypernatremia is a common electrolyte disorder and is frequently caused iatrogenically <TextLink reference="12"></TextLink>, <TextLink reference="20"></TextLink>, <TextLink reference="21"></TextLink>. Hypernatremia (>146 mmol/l) is a reliable marker for systemic dehydration <TextLink reference="16"></TextLink>. Even a short period of hypernatremia may lead to an induction of apoptosis apart from its neurologic effects <TextLink reference="22"></TextLink>, <TextLink reference="23"></TextLink>. Serum sodium is easy to evaluate in an ICU setting by blood gas analysis and provides additional information about the patients’ systemic fluid status <TextLink reference="24"></TextLink>. Patients admitted to an ICU have a higher incidence of hypernatremia compared to general hospital population and there is a strong correlation in peak serum sodium level and mortality <TextLink reference="16"></TextLink>. </Pgraph><Pgraph>In the study of Bastuji-Garin et al. <TextLink reference="10"></TextLink> serum sodium imbalance (hypo- and hypernatremia) was shown to have a significant univariate association to patients’ survival. Multivariate analysis failed to prove a hypernatremic state as an independent predictor of death. Hence, serum sodium imbalance was not included in the SCORTEN-formula. </Pgraph><Pgraph>The aim of our study was to elucidate the impact of hypernatremia in the mortality of TEN patients. Individuals with an epidermolytic surface <30% TBSA were excluded from this study. There was a significantly higher mean serum sodium level at admission in Group B (with hypernatremia), but only 2 individuals showed abnormally high values (>146 mmol/l). The other Group B patients showed normal serum sodium levels at admission. In-hospital acquired hypernatremia (Group B) occurred on day 3.3±2.4 after admission. The mean daily IDR for the two analyzed periods (day 1 to 4 and day 1 to 10) was higher in the hypernatremic subgroup, but statistical analysis did not show any significance. We registered a mortality rate of 36% in all analyzed TEN-patients, which is at the lower range of prior reported studies <TextLink reference="6"></TextLink>, <TextLink reference="8"></TextLink>, <TextLink reference="9"></TextLink>, <TextLink reference="25"></TextLink>. Only 1 normonatremic individual died within 60 days after admission. 13 patients (52%) developed a hypernatremic state during Burn Unit stay. We registered a significantly higher mortality in hypernatremic patients than in normonatremic patients (Figure 1 <ImgLink imgNo="1" imgType="figure"/>). The mortality rate of h<TextGroup><PlainText>ype</PlainText></TextGroup>rnatremic TEN patients (60%) was comparable to the results of other hypernatremic non-TEN studies (31% to 66%) <TextLink reference="13"></TextLink>, <TextLink reference="14"></TextLink>, <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>, <TextLink reference="17"></TextLink>, <TextLink reference="18"></TextLink>, <TextLink reference="19"></TextLink>. </Pgraph><Pgraph>We assume that patients with a TEN have an increased risk of systemic dehydration. One explanation may be the amount of transdermal fluid loss (epidermolysis >30% TBSA) and the painful limitation of oral feeding and fluid uptake due to erosive mucous membrane lesions. On the other hand, termination of the patient's prior medication at admission – as an elementary step in TEN treatment – can provoke alterations in urinary output. In our study a significantly higher diuresis was detected in patients with hypernatremia (Group B), but no larger amount of administered diuretics was registered. A hypernatremic state in TEN patients is a symptom, which may provoke severe complications such as an increased mortality. The reason for increased mortality in hypernatremic patients could not be identified in our study. Even previous studies, focused on hypernatremia and mortality, could not elaborate the specific mechanisms by which hypernatremia leads to increased mortality <TextLink reference="13"></TextLink>, <TextLink reference="14"></TextLink>, <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>, <TextLink reference="17"></TextLink>, <TextLink reference="18"></TextLink>, <TextLink reference="19"></TextLink>, <TextLink reference="26"></TextLink>. There was a significantly higher SCORTEN at admission in Group B, which indicates an increased severity of illness in these patients compared to normonatremic patients. </Pgraph><Pgraph>We conclude that even in specialized Burn Units the incidence of hypernatremia in TEN patients is unavoidable. In case of a hypernatremic state early intervention is obligatory. Short interval blood gas analysis is advisable to register water imbalances early. An arterial line offers easy electrolyte control besides continuous blood pressure monitoring as well as control of pulmonary gas exchange parameters. In a life-threatening disease like TEN we strongly recommend this approach to optimize hemodynamic monitoring. Early transferral of TEN patients to regional Burn Units for critical care management and optimized wound care has been shown to have a positive effect on survival <TextLink reference="5"></TextLink>.</Pgraph><SubHeadline>Limitations</SubHeadline><Pgraph>In this retrospective study we analyzed only a small population of hypernatremic TEN patients. There was no standardized protocol for fluid administration protocol after admission. The collected values and findings only have an empiric character and should be investigated by prospective randomized clinical trials.</Pgraph></TextBlock>
<TextBlock linked="yes" name="Notes">
<MainHeadline>Notes</MainHeadline><SubHeadline>Competing interests</SubHeadline><Pgraph>The authors declare that they have no competing i<TextGroup><PlainText>nte</PlainText></TextGroup>rests.</Pgraph></TextBlock>
<References linked="yes">
<Reference refNo="1">
<RefAuthor>Mockenhaupt M</RefAuthor>
<RefAuthor>Norgauer</RefAuthor>
<RefAuthor>J</RefAuthor>
<RefTitle>Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis</RefTitle>
<RefYear>2002</RefYear>
<RefJournal>Allergy Clin Immunol Int</RefJournal>
<RefPage>143-50</RefPage>
<RefTotal>Mockenhaupt M, Norgauer, J. Cutaneous adverse drug reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergy Clin Immunol Int. 2002;14(4):143-50. DOI: 10.1027/0838-1925.14.4.143</RefTotal>
<RefLink>http://dx.doi.org/10.1027/0838-1925.14.4.143</RefLink>
</Reference>
<Reference refNo="2">
<RefAuthor>Rzany B</RefAuthor>
<RefAuthor>Mockenhaupt M</RefAuthor>
<RefAuthor>Baur S</RefAuthor>
<RefAuthor>Schröder W</RefAuthor>
<RefAuthor>Stocker U</RefAuthor>
<RefAuthor>Mueller J</RefAuthor>
<RefAuthor>Holländer N</RefAuthor>
<RefAuthor>Bruppacher R</RefAuthor>
<RefAuthor>Schöpf E</RefAuthor>
<RefTitle>Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry</RefTitle>
<RefYear>1996</RefYear>
<RefJournal>J Clin Epidemiol</RefJournal>
<RefPage>769-73</RefPage>
<RefTotal>Rzany B, Mockenhaupt M, Baur S, Schröder W, Stocker U, Mueller J, Holländer N, Bruppacher R, Schöpf E. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990–1992): structure and results of a population-based registry. J Clin Epidemiol. 1996;49(7):769-73. DOI: 10.1016/0895-4356(96)00035-2</RefTotal>
<RefLink>http://dx.doi.org/10.1016/0895-4356(96)00035-2</RefLink>
</Reference>
<Reference refNo="3">
<RefAuthor>Arndt KA</RefAuthor>
<RefAuthor>Feingold DS</RefAuthor>
<RefTitle>The sign of Pyotr Vasilyewich Nikolsky</RefTitle>
<RefYear>1970</RefYear>
<RefJournal>N Engl J Med</RefJournal>
<RefPage>1154-5</RefPage>
<RefTotal>Arndt KA, Feingold DS. The sign of Pyotr Vasilyewich Nikolsky. N Engl J Med. 1970;282(20):1154-5. DOI: 10.1056/NEJM197005142822011</RefTotal>
<RefLink>http://dx.doi.org/10.1056/NEJM197005142822011</RefLink>
</Reference>
<Reference refNo="4">
<RefAuthor>Rzany B</RefAuthor>
<RefAuthor>Hering O</RefAuthor>
<RefAuthor>Mockenhaupt M</RefAuthor>
<RefAuthor>Schröder W</RefAuthor>
<RefAuthor>Goerttler E</RefAuthor>
<RefAuthor>Ring J</RefAuthor>
<RefAuthor>Schöpf E</RefAuthor>
<RefTitle>Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis</RefTitle>
<RefYear>1996</RefYear>
<RefJournal>Br J Dermatol</RefJournal>
<RefPage>6-11</RefPage>
<RefTotal>Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 1996;135(1):6-11</RefTotal>
</Reference>
<Reference refNo="5">
<RefAuthor>Spies M</RefAuthor>
<RefAuthor>Vogt PM</RefAuthor>
<RefAuthor>Herndon DN</RefAuthor>
<RefTitle>Toxisch epidermale Nekrolyse. Ein Fall für das Schwerverbranntenzentrum</RefTitle>
<RefYear>2003</RefYear>
<RefJournal>Chirurg</RefJournal>
<RefPage>452-60</RefPage>
<RefTotal>Spies M, Vogt PM, Herndon DN. Toxisch epidermale Nekrolyse. Ein Fall für das Schwerverbranntenzentrum [Toxic epidermal necrolysis. A case for the burn intensive care unit]. Chirurg. 2003;74(5):452-60. DOI: 10.1007/s00104-002-0571-9</RefTotal>
<RefLink>http://dx.doi.org/10.1007/s00104-002-0571-9</RefLink>
</Reference>
<Reference refNo="6">
<RefAuthor>Correia O</RefAuthor>
<RefAuthor>Chosidow O</RefAuthor>
<RefAuthor>Saiag P</RefAuthor>
<RefAuthor>Bastuji-Garin S</RefAuthor>
<RefAuthor>Revuz J</RefAuthor>
<RefAuthor>Roujeau JC</RefAuthor>
<RefTitle>Evolving pattern of drug-induced toxic epidermal necrolysis</RefTitle>
<RefYear>1993</RefYear>
<RefJournal>Dermatology</RefJournal>
<RefPage>32-7</RefPage>
<RefTotal>Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology. 1993;186(1):32-7. DOI: 10.1159/000247299</RefTotal>
<RefLink>http://dx.doi.org/10.1159/000247299</RefLink>
</Reference>
<Reference refNo="7">
<RefAuthor>McGee T</RefAuthor>
<RefAuthor>Munster A</RefAuthor>
<RefTitle>Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center</RefTitle>
<RefYear>1998</RefYear>
<RefJournal>Plast Reconstr Surg</RefJournal>
<RefPage>1018-22</RefPage>
<RefTotal>McGee T, Munster A. Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg. 1998;102(4):1018-22. DOI: 10.1097/00006534-199809040-00014</RefTotal>
<RefLink>http://dx.doi.org/10.1097/00006534-199809040-00014</RefLink>
</Reference>
<Reference refNo="8">
<RefAuthor>Revuz J</RefAuthor>
<RefAuthor>Penso D</RefAuthor>
<RefAuthor>Roujeau JC</RefAuthor>
<RefAuthor>Guillaume JC</RefAuthor>
<RefAuthor>Payne CR</RefAuthor>
<RefAuthor>Wechsler J</RefAuthor>
<RefAuthor>Touraine R</RefAuthor>
<RefTitle>Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients</RefTitle>
<RefYear>1987</RefYear>
<RefJournal>Arch Dermatol</RefJournal>
<RefPage>1160-5</RefPage>
<RefTotal>Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Wechsler J, Touraine R. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol. 1987;123(9):1160-5.</RefTotal>
</Reference>
<Reference refNo="9">
<RefAuthor>Roujeau JC</RefAuthor>
<RefAuthor>Stern RS</RefAuthor>
<RefTitle>Severe adverse cutaneous reactions to drugs</RefTitle>
<RefYear>1994</RefYear>
<RefJournal>N Engl J Med</RefJournal>
<RefPage>1272-85</RefPage>
<RefTotal>Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331(19):1272-85. DOI: 10.1056/NEJM199411103311906</RefTotal>
<RefLink>http://dx.doi.org/10.1056/NEJM199411103311906</RefLink>
</Reference>
<Reference refNo="10">
<RefAuthor>Bastuji-Garin S</RefAuthor>
<RefAuthor>Fouchard N</RefAuthor>
<RefAuthor>Bertocchi M</RefAuthor>
<RefAuthor>Roujeau JC</RefAuthor>
<RefAuthor>Revuz J</RefAuthor>
<RefAuthor>Wolkenstein P</RefAuthor>
<RefTitle>SCORTEN: a severity-of-illness score for toxic epidermal necrolysis</RefTitle>
<RefYear>2000</RefYear>
<RefJournal>J Invest Dermatol</RefJournal>
<RefPage>149-53</RefPage>
<RefTotal>Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115(2):149-53. DOI: 10.1046/j.1523-1747.2000.00061.x</RefTotal>
<RefLink>http://dx.doi.org/10.1046/j.1523-1747.2000.00061.x</RefLink>
</Reference>
<Reference refNo="11">
<RefAuthor>Adrogué HJ</RefAuthor>
<RefAuthor>Madias NE</RefAuthor>
<RefTitle>Hypernatremia</RefTitle>
<RefYear>2000</RefYear>
<RefJournal>N Engl J Med</RefJournal>
<RefPage>1493-9</RefPage>
<RefTotal>Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493-9. DOI: 10.1056/NEJM200005183422006</RefTotal>
<RefLink>http://dx.doi.org/10.1056/NEJM200005183422006</RefLink>
</Reference>
<Reference refNo="12">
<RefAuthor>Lin M</RefAuthor>
<RefAuthor>Liu SJ</RefAuthor>
<RefAuthor>Lim IT</RefAuthor>
<RefTitle>Disorders of water imbalance</RefTitle>
<RefYear>2005</RefYear>
<RefJournal>Emerg Med Clin North Am</RefJournal>
<RefPage>749-70, ix</RefPage>
<RefTotal>Lin M, Liu SJ, Lim IT. Disorders of water imbalance. Emerg Med Clin North Am. 2005;23(3):749-70, ix. DOI: 10.1016/j.emc.2005.03.001</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.emc.2005.03.001</RefLink>
</Reference>
<Reference refNo="13">
<RefAuthor>Palevsky PM</RefAuthor>
<RefAuthor>Bhagrath R</RefAuthor>
<RefAuthor>Greenberg A</RefAuthor>
<RefTitle>Hypernatremia in hospitalized patients</RefTitle>
<RefYear>1996</RefYear>
<RefJournal>Ann Intern Med</RefJournal>
<RefPage>197-203</RefPage>
<RefTotal>Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med. 1996;124(2):197-203.</RefTotal>
</Reference>
<Reference refNo="14">
<RefAuthor>O'Connor KA</RefAuthor>
<RefAuthor>Cotter PE</RefAuthor>
<RefAuthor>Kingston M</RefAuthor>
<RefAuthor>Twomey C</RefAuthor>
<RefAuthor>O'Mahony D</RefAuthor>
<RefTitle>The pattern of plasma sodium abnormalities in an acute elderly care ward: a cross-sectional study</RefTitle>
<RefYear>2006</RefYear>
<RefJournal>Ir J Med Sci</RefJournal>
<RefPage>28-31</RefPage>
<RefTotal>O'Connor KA, Cotter PE, Kingston M, Twomey C, O'Mahony D. The pattern of plasma sodium abnormalities in an acute elderly care ward: a cross-sectional study. Ir J Med Sci. 2006;175(3):28-31.</RefTotal>
</Reference>
<Reference refNo="15">
<RefAuthor>Mandal AK</RefAuthor>
<RefAuthor>Saklayen MG</RefAuthor>
<RefAuthor>Hillman NM</RefAuthor>
<RefAuthor>Markert RJ</RefAuthor>
<RefTitle>Predictive factors for high mortality in hypernatremic patients</RefTitle>
<RefYear>1997</RefYear>
<RefJournal>Am J Emerg Med</RefJournal>
<RefPage>130-2</RefPage>
<RefTotal>Mandal AK, Saklayen MG, Hillman NM, Markert RJ. Predictive factors for high mortality in hypernatremic patients. Am J Emerg Med. 1997;15(2):130-2. DOI: 10.1016/S0735-6757(97)90082-6</RefTotal>
<RefLink>http://dx.doi.org/10.1016/S0735-6757(97)90082-6</RefLink>
</Reference>
<Reference refNo="16">
<RefAuthor>Aiyagari V</RefAuthor>
<RefAuthor>Deibert E</RefAuthor>
<RefAuthor>Diringer MN</RefAuthor>
<RefTitle>Hypernatremia in the neurologic intensive care unit: how high is too high?</RefTitle>
<RefYear>2006</RefYear>
<RefJournal>J Crit Care</RefJournal>
<RefPage>163-72</RefPage>
<RefTotal>Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care. 2006;21(2):163-72. DOI: 10.1016/j.jcrc.2005.10.002</RefTotal>
<RefLink>http://dx.doi.org/10.1016/j.jcrc.2005.10.002</RefLink>
</Reference>
<Reference refNo="17">
<RefAuthor>Hoorn EJ</RefAuthor>
<RefAuthor>Betjes MG</RefAuthor>
<RefAuthor>Weigel J</RefAuthor>
<RefAuthor>Zietse R</RefAuthor>
<RefTitle>Hypernatraemia in critically ill patients: too little water and too much salt</RefTitle>
<RefYear>2008</RefYear>
<RefJournal>Nephrol Dial Transplant</RefJournal>
<RefPage>1562-8</RefPage>
<RefTotal>Hoorn EJ, Betjes MG, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant. 2008;23(5):1562-8. DOI: 10.1093/ndt/gfm831</RefTotal>
<RefLink>http://dx.doi.org/10.1093/ndt/gfm831</RefLink>
</Reference>
<Reference refNo="18">
<RefAuthor>Lindner G</RefAuthor>
<RefAuthor>Funk GC</RefAuthor>
<RefAuthor>Schwarz C</RefAuthor>
<RefAuthor>Kneidinger N</RefAuthor>
<RefAuthor>Kaider A</RefAuthor>
<RefAuthor>Schneeweiss B</RefAuthor>
<RefAuthor>Kramer L</RefAuthor>
<RefAuthor>Druml W</RefAuthor>
<RefTitle>Hypernatremia in the critically ill is an independent risk factor for mortality</RefTitle>
<RefYear>2007</RefYear>
<RefJournal>Am J Kidney Dis</RefJournal>
<RefPage>952-7</RefPage>
<RefTotal>Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, Druml W. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50(6):952-7. DOI: 10.1053/j.ajkd.2007.08.016</RefTotal>
<RefLink>http://dx.doi.org/10.1053/j.ajkd.2007.08.016</RefLink>
</Reference>
<Reference refNo="19">
<RefAuthor>Polderman KH</RefAuthor>
<RefAuthor>Schreuder WO</RefAuthor>
<RefAuthor>Strack van Schijndel RJ</RefAuthor>
<RefAuthor>Thijs LG</RefAuthor>
<RefTitle>Hypernatremia in the intensive care unit: an indicator of quality of care?</RefTitle>
<RefYear>1999</RefYear>
<RefJournal>Crit Care Med</RefJournal>
<RefPage>1105-8</RefPage>
<RefTotal>Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999;27(6):1105-8. DOI: 10.1097/00003246-199906000-00029</RefTotal>
<RefLink>http://dx.doi.org/10.1097/00003246-199906000-00029</RefLink>
</Reference>
<Reference refNo="20">
<RefAuthor>Janz T</RefAuthor>
<RefTitle>Sodium</RefTitle>
<RefYear>1986</RefYear>
<RefJournal>Emerg Med Clin North Am</RefJournal>
<RefPage>115-30</RefPage>
<RefTotal>Janz T. Sodium. Emerg Med Clin North Am. 1986;4(1):115-30.</RefTotal>
</Reference>
<Reference refNo="21">
<RefAuthor>Snyder NA</RefAuthor>
<RefAuthor>Feigal DW</RefAuthor>
<RefAuthor>Arieff AI</RefAuthor>
<RefTitle>Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity</RefTitle>
<RefYear>1987</RefYear>
<RefJournal>Ann Intern Med</RefJournal>
<RefPage>309-19</RefPage>
<RefTotal>Snyder NA, Feigal DW, Arieff AI. Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann Intern Med. 1987;107(3):309-19.</RefTotal>
</Reference>
<Reference refNo="22">
<RefAuthor>Harada T</RefAuthor>
<RefAuthor>Izaki S</RefAuthor>
<RefAuthor>Tsutsumi H</RefAuthor>
<RefAuthor>Kobayashi M</RefAuthor>
<RefAuthor>Kitamura K</RefAuthor>
<RefTitle>Apoptosis of hair follicle cells in the second-degree burn wound unders hypernatremic conditions</RefTitle>
<RefYear>1998</RefYear>
<RefJournal>Burns</RefJournal>
<RefPage>464-9</RefPage>
<RefTotal>Harada T, Izaki S, Tsutsumi H, Kobayashi M, Kitamura K. Apoptosis of hair follicle cells in the second-degree burn wound unders hypernatremic conditions. Burns. 1998;24(5):464-9. DOI: 10.1016/S0305-4179(98)00034-5</RefTotal>
<RefLink>http://dx.doi.org/10.1016/S0305-4179(98)00034-5</RefLink>
</Reference>
<Reference refNo="23">
<RefAuthor>Kuroda T</RefAuthor>
<RefAuthor>Harada T</RefAuthor>
<RefAuthor>Tsutsumi H</RefAuthor>
<RefAuthor>Kobayashi M</RefAuthor>
<RefTitle>Hypernatremia deepens the demarcating borderline of leukocytic infiltration in the burn wound</RefTitle>
<RefYear>1997</RefYear>
<RefJournal>Burns</RefJournal>
<RefPage>432-7</RefPage>
<RefTotal>Kuroda T, Harada T, Tsutsumi H, Kobayashi M. Hypernatremia deepens the demarcating borderline of leukocytic infiltration in the burn wound. Burns. 1997;23(5):432-7. DOI: 10.1016/S0305-4179(97)00016-8</RefTotal>
<RefLink>http://dx.doi.org/10.1016/S0305-4179(97)00016-8</RefLink>
</Reference>
<Reference refNo="24">
<RefAuthor>Sterns RH</RefAuthor>
<RefTitle>Hypernatremia in the intensive care unit: instant quality – just add water</RefTitle>
<RefYear>1999</RefYear>
<RefJournal>Crit Care Med</RefJournal>
<RefPage>1041-2</RefPage>
<RefTotal>Sterns RH. Hypernatremia in the intensive care unit: instant quality – just add water. Crit Care Med. 1999;27(6):1041-2. DOI: 10.1097/00003246-199906000-00005</RefTotal>
<RefLink>http://dx.doi.org/10.1097/00003246-199906000-00005</RefLink>
</Reference>
<Reference refNo="25">
<RefAuthor>Ginsburg CM</RefAuthor>
<RefTitle>Stevens-Johnson syndrome in children</RefTitle>
<RefYear>1982</RefYear>
<RefJournal>Pediatr Infect Dis</RefJournal>
<RefPage>155-8</RefPage>
<RefTotal>Ginsburg CM. Stevens-Johnson syndrome in children. Pediatr Infect Dis. 1982;1(3):155-8.</RefTotal>
</Reference>
<Reference refNo="26">
<RefAuthor>O'Donoghue SD</RefAuthor>
<RefAuthor>Dulhunty JM</RefAuthor>
<RefAuthor>Bandeshe HK</RefAuthor>
<RefAuthor>Senthuran S</RefAuthor>
<RefAuthor>Gowardman JR</RefAuthor>
<RefTitle>Acquired hypernatraemia is an independent predictor of mortality in critically ill patients</RefTitle>
<RefYear>2009</RefYear>
<RefJournal>Anaesthesia</RefJournal>
<RefPage>514-20</RefPage>
<RefTotal>O'Donoghue SD, Dulhunty JM, Bandeshe HK, Senthuran S, Gowardman JR. Acquired hypernatraemia is an independent predictor of mortality in critically ill patients. Anaesthesia. 2009;64(5):514-20. DOI: 10.1111/j.1365-2044.2008.05857.x</RefTotal>
<RefLink>http://dx.doi.org/10.1111/j.1365-2044.2008.05857.x</RefLink>
</Reference>
</References>
<Media>
<Tables>
<Table format="png">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Table 1: Patients characteristics divided in Group A (without hypernatremia) and Group B (with hypernatremia). 10-days-diuresis [ml/kg/hours], serum sodium level on admission [mmol/l], age [years], TBSA [%], SCORTEN-Score, mean amount of daily administered furorese [mg/day], mean daily infusion-diuresis-ratio (IDR) [ml] for two periods (day 1 to 4 and day 1 to 10) of each subgroup is displayed with values for mean, standard deviation (SD), minimum, maximum and p-value.</Mark1></Pgraph></Caption>
</Table>
<NoOfTables>1</NoOfTables>
</Tables>
<Figures>
<Figure format="png" height="548" width="648">
<MediaNo>1</MediaNo>
<MediaID>1</MediaID>
<Caption><Pgraph><Mark1>Figure 1: Survival curves according to the TEN patients with an in-hospital acquired hypernatremic state. The probability of hospital mortality over time was determined using Kaplan-Meier survival analysis. Logrank (Mantel-Cox) analysis evidenced a significant difference between Group A (normonatremic) and Group B (hypernatremic) curves.</Mark1></Pgraph></Caption>
</Figure>
<NoOfPictures>1</NoOfPictures>
</Figures>
<InlineFigures>
<NoOfPictures>0</NoOfPictures>
</InlineFigures>
<Attachments>
<NoOfAttachments>0</NoOfAttachments>
</Attachments>
</Media>
</OrigData>
</GmsArticle>]]></plaintext></textgroup></pgraph></textblock></origdata></gmsarticle>